QFR is simplified & cost effective way of functional testing without any potential for complications during testing. Has the potential to become part of every angiogram lesion estimation in future thus helping in avoiding unnecessary PCIs & Stenting. We should all work together to make this happen for the benefit of all our patients. Congratulations to Medis.
Dr. A. Sreenivas Kumar, M.D., D.M., FACC
Chairman, Cardiovascular Sciences & Chief Cardiologist Citizens Hospital Nallagandla, Hyderabad
QAngio XA has proven to be very intuitive and easy to learn, even with the challenging cases in our large real-world population trial. It allows us to perform a high volume of quantitative angiographic analyses with limited personnel.
Clemens von Birgelen, PD PhD
Professor of Interventional Cardiology, University of Twente,
Enschede, the Netherlands
Associate Professor of Medicine (PD), University of Duisburg-Essen,
Interventional Cardiologist and Co-Director, Department of Cardiology, Thoraxcentrum Twente, Enschede, the Netherlands
Our experience with QAngio XA revealed consistent, valid and reproducible intra- and inter-observer results with shorter analysis times both in QCA and QVA analysis in a multitude of large, multi-center device trials with angiographic endpoints.
Prof. Johannes B. Dahm, MD
Professor of Clinical Medicine, Cardiology, Angiology
Director, Clinical Services, Heart-& Vascular Center Neu Bethlehem
Director Core Laboratories imaeon scientific research and genae associates
We have been using the Medis QAngio XA software in our core laboratory since 1991. All major interventional device trials with angiographic endpoints have been evaluated using Medis QAngio XA as the standard.
Alexandra J. Lansky, MD
Associate Professor of Clinical Medicine
Director, Clinical Services, Center for Interventional Vascular Therapy
Columbia University Medical Center
Joint Chief Scientific Officer, Clinical Trial Center
and Director, Women's Cardiovascular Health Initiative
Cardiovascular Research Foundation
The Nordic Bifurcation Study Group has used the QAngio XA bifurcation software for the analyses of the angiographic endpoints in our studies. It is our opinion that QAngio XA sets the current standard for angiographic 2-D evaluation of bifurcation lesions.
Michael Maeng, MD, PhD
Department of Cardiology
Aarhus University Hospital, Skejby
Our results demonstrate that the new QAngio XA bifurcation software can be consistently applied to the analysis of bifurcation lesions before and after angioplasty, with an intra- and interobserver reproducibility equal to or better than the conventional analysis system and a significantly shorter analysis time.
Carlo Di Mario, MD, PhD
Professor in Cardiology
National Heart and Lung Institute
Imperial College, London
At the VUmc we work with QMass MR and QFlow plugged into our Sectra PACS. We are very pleased with the workflow as the integration is seamless, the Medis apps are very easy to use and save us a lot of time processing CMR cases.
Aernout Beek, MD, PhD
Department of Cardiology
VU Medical Center
Amsterdam, The Netherlands
Our group members are really satisfied with QMass MR, especially with rapid imaging processing time and easy quantitative analysis. It shortens much
of our work time for clinical reporting and data storage. I also appreciate their continuous efforts for updating software upon consumers needs.
Eui-Young Choi, MD, PhD
Head Cardiac Imaging Team
Division of Cardiology, Heart Center
Gangnam Severance Hospital
Yonsei University College of Medicine, Seoul, South Korea
We use QMass and QFlow with great satisfaction. The software can be used instinctively with only little training. It is possible to quickly make reports and add figures with great ease. Most of all, we appreciate that Medis is listening to and working with their customers to further improve the user-friendliness of their software and develop new tools for analysis of cardiac MRI.
Tineke P Willems, MD, PhD
University Medical Center Groningen
University of Groningen
Groningen, The Netherlands
For almost ten years, we rely on the applications that Medis offers for processing CMR and CT function cases as well. Nowadays, our 3D lab takes care of the lion’s share in performing quantitative analysis. We recommend Medis in any busy clinical practice.
Dr. Frandics Chan, MD, PhD
Department of Radiology
Stanford University Medical Center
We have been using QMass MR for more than 10 years and we still see it as the more reliable and user-friendly workstation. Most interesting for a large, high-output Cardiac Imaging Unit like ours, is the independence it allows from console-bound stations or systems from different vendors. We also appreciate the frequent updates of the resources of the package that make the whole system an essential tool not only for daily practice, but also for educational and research purposes.
Guillem Pons-Lladó, MD, PhD, FAHA
Director, Cardiac Imaging Unit
Hospital de Sant Pau
Autonomous University of Barcelona
We rely on QMass MR for rapid quantitative analysis of cardiac function as well as for visual review of cardiac function and perfusion. It is more stable and reliable than many other viewers and PACS software, and we have used it consistently for the past 8 years. QMass MR has an excellent user interface that is easily learned by both our technologists and physicians.
David A. Bluemke, MD, PhD
Professor of Radiology and Medicine
Clinical Director of MRI, Department of Radiology
Johns Hopkins University School of Medicine
Medis is one of the first to recognize the importance of the right ventricle for pediatric cardiologists. Their tools generate quantitative assessments of right ventricular size, function and mass, which is invaluable in the management of many of our patients.
The QMass MR tool for quantification of delayed enhancement supports our research in a field of growing interest.
Prof. Dr. Jeanette Schulz-Menger
Cardiologist, Head Cardiac MRI Team
Charité Campus Buch, University Berlin
I have been using the new QMass MR 7.2 version for some time now, and I must say that the latest enhancements in the interface have significantly improved the user experience. This new release really makes a difference to me.
Attila Toth, MD
Heart Center, Semmelweis University
With its streamlined interface, automatic RV contour detection, and improved LV contour detection, QMass® MR 7.1 makes working with MR studies as easy and as time-efficient for us as working with echo.
Uma Valeti, MD
Director of Cardiovascular MRI and CT
St. Paul Heart Clinic